This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by SALVI, M. Articles by WALL, J. R. Search for Related Content PubMed PubMed Citation Articles by SALVI, M. Articles by WALL, J. R.

Patients with Endocrine Ophthalmopathy not Associated with Overt Thyroid Disease Have Multiple Thyroid Immunological Abnormalities^*

Thyroid Research Unit, Montreal General Hospital Montreal, Quebec, H3G1A4, Canada

Address requests for reprints to: Dr. M. Salvi, Thyroid Research Unit, Montreal General Hospital, 1650 Cedar Avenue, Montreal, Quebec, H3G1A4 Canada.

Twenty-two apparently euthyroid patients with endocrine ophthalmopathy not associated with goiter, antithyroid microsomal or antithyroglobulin antibodies, or overt thyroid disease (so-called ophthalmic Graves' disease) were tested for subclinical hyperthyroidism or hypothyroidism. We measured ¹³¹I uptake and scan, serum T₃ (by RIA), and serum TSH using a sensitive (by immunoradiometric assay) assay. Three patients were found to be hyperthyroid, and 1 was hypothyroid. The remaining 18 patients, who remained euthyroid throughout the study period, were investigated for evidence for antibody-mediated immunity against thyroid antigens. We measured antibody- dependent cell-mediated cytotoxicity against fresh thyroid cells using a 61chromium release assay, thyroid membrane-reactive antibodies in an enzyme-linked immunosorbent assay incorporating solubilized thyroid membranes, and TSH receptorbinding antibodies using a RRA and carried out sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting with patient sera for antibodies reactive with 64 and 110 kDa (thyroid peroxidase) membrane proteins. Bands were demonstrated, on SDS-PAGE, at 64 or 110 kDa in 13 patients, antibody-dependent cell-mediated cytotoxicity tests were positive in 7 patients, and enzyme-linked immunosorbent assay was positive in 4 of the 17 patients tested. In addition, TSH receptor antibody tests were positive in 5 patients, none of whom had other evidence for hyperthyroidism. Finally, significant lymphocyte infiltration was demonstrated on aspiration biopsy in 3 patients. All 18 patients had positive tests in at least 1 of the immunological assays. We believe that these data support the hypothesis that endocrine ophthalmopathy always occurs in patients with overt or subclinical Graves' hyperthyroidism, Hashimoto's thyroiditis, or thyroid immunological abnormalities. Those patients previously described as having euthyroid Graves' disease should, thus, be considered to have associated thyroid immunological abnormalities even though histological confirmation (from aspiration needle biopsy) may be obtained in only a minority of the patients. The possibility that the mechanism for this close association is cross-reactivity of cytotoxic antibodies against a thyroid/eye muscle cell surface shared antigen is discussed in the context of recent evidence from the authors' laboratory.

^* This work was supported by grants from the Medical Research Council of Canada; the NEI, NIH; the CNR of Italy; and the Thyroid Foundation of Canada.

Received February 16, 1989.

This article has been cited by other articles:

				P. Perros, C. Neoh, and J. Dickinson Thyroid eye disease BMJ, March 6, 2009; 338(mar06_1): b560 - b560. [Full Text]

				J M Kim, L LaBree, L Levin, and S E Feldon The relation of Graves' ophthalmopathy to circulating thyroid hormone status Br J Ophthalmol, January 1, 2004; 88(1): 72 - 74. [Abstract] [Full Text] [PDF]

				B. S. Prabhakar, R. S. Bahn, and T. J. Smith Current Perspective on the Pathogenesis of Graves' Disease and Ophthalmopathy Endocr. Rev., December 1, 2003; 24(6): 802 - 835. [Abstract] [Full Text] [PDF]

				R. S. Bahn Pathophysiology of Graves' Ophthalmopathy: The Cycle of Disease J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1939 - 1946. [Full Text] [PDF]

				A C Al-Abadi Subclinical thyrotoxicosis Postgrad. Med. J., January 1, 2001; 77(903): 29 - 29. [Full Text]

				K. Kazuo, T. Fujikado, G. Ohmi, J. Hosohata, and Y. Tano Value of thyroid stimulating antibody in the diagnosis of thyroid associated ophthalmopathy of euthyroid patients Br J Ophthalmol, December 1, 1997; 81(12): 1080 - 1083. [Abstract] [Full Text] [PDF]

				R. S. Bahn and A. E. Heufelder Pathogenesis of Graves' Ophthalmopathy N. Engl. J. Med., November 11, 1993; 329(20): 1468 - 1475. [Full Text]

				D. L. Kendler, J. Lippa, and J. Rootman The Initial Clinical Characteristics of Graves' Orbitopathy Vary With Age and Sex Arch Ophthalmol, February 1, 1993; 111(2): 197 - 201. [Abstract] [PDF]